Influence of Oxygen on Non-invasive Measurement of Hemoglobin (Hb-O2)

This study has been completed.
Information provided by (Responsible Party):
Hopital Foch Identifier:
First received: July 16, 2012
Last updated: March 25, 2015
Last verified: March 2015
This study examines the effect of oxygen supplementation on the non-invasive measurement of hemoglobin.

Condition Intervention
Device: hemoglobin measurement

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Influence of the Inspired Oxygen Fraction on the Noninvasive Measurement of Hemoglobin Using Two Different Devices (Namely Pronto 7 and NBM-200)

Resource links provided by NLM:

Further study details as provided by Hopital Foch:

Primary Outcome Measures:
  • influence of the inspired oxygen fraction on the noninvasive measurement of hemoglobin (Pronto 7 and NBM-200 devices) [ Time Frame: one year (end of the recrutement period) ] [ Designated as safety issue: No ]
    Statistical comparison of the 3 measurements (baseline, FiO2 50%, FiO295%) for each device

Secondary Outcome Measures:
  • agreement between the noninvasive methods of measurement of hemoglobin and the laboratory analysis [ Time Frame: one year (end of the recrutement period) ] [ Designated as safety issue: No ]
    Statistical comparison of the 2 devices

Enrollment: 47
Study Start Date: July 2012
Study Completion Date: November 2014
Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: surgical patients
patients studied just before induction of anesthesia
Device: hemoglobin measurement

Non invasive hemoglobin measurements (Pronto 7 device and NBM-200 device)will be made with :

  • at baseline (simultaneous blood sample for a laboratory measurement of hemoglobin),
  • with the patient breathing oxygen via a face-mask (FiO2 50 ± 5%),
  • with the patient breathing oxygen via a face-mask (FiO2 90 ± 5%) (simultaneous blood sample for a laboratory measurement of hemoglobin).


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • adult patients scheduled for a potentially hemorrhagic surgical procedure

Exclusion Criteria:

  • anomaly (malformation, infection, swelling, irritation, ulceration, degenerative changes or significant edema) of the fingers,
  • tremors.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01654913

Hopital Lariboisière
Paris, France, 75010
Hopital Foch
Suresnes, France, 92151
Sponsors and Collaborators
Hopital Foch
  More Information

Responsible Party: Hopital Foch Identifier: NCT01654913     History of Changes
Other Study ID Numbers: 2012/16 
Study First Received: July 16, 2012
Last Updated: March 25, 2015
Health Authority: France: Direction Générale de la Santé

Keywords provided by Hopital Foch:
hemoglobin determination
oxygen processed this record on April 27, 2016